Growing community of inventors

Vossellar, Belgium

Jozef Ludo Jan Cuypers

Average Co-Inventor Count = 6.18

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Jozef Ludo Jan CuypersAndras Horvath (2 patents)Jozef Ludo Jan CuypersDominique Paul Michel Depré (2 patents)Jozef Ludo Jan CuypersStijn Wuyts (2 patents)Jozef Ludo Jan CuypersWouter Louis J Couck (2 patents)Jozef Ludo Jan CuypersSyuzanna Harutyunyan (2 patents)Jozef Ludo Jan CuypersGregory Fabien Sebastian Binot (2 patents)Jozef Ludo Jan CuypersMichel Joseph Maurice André Guillaume (1 patent)Jozef Ludo Jan CuypersStefan Marcel Herman Leurs (1 patent)Jozef Ludo Jan CuypersDirk De Smaele (1 patent)Jozef Ludo Jan CuypersIvan Joseph Maria Vervest (1 patent)Jozef Ludo Jan CuypersDominique Paul Michel DeprÉ (0 patent)Jozef Ludo Jan CuypersGregory Fabien Sebastien Binot (0 patent)Jozef Ludo Jan CuypersJozef Ludo Jan Cuypers (3 patents)Andras HorvathAndras Horvath (17 patents)Dominique Paul Michel DepréDominique Paul Michel Depré (9 patents)Stijn WuytsStijn Wuyts (4 patents)Wouter Louis J CouckWouter Louis J Couck (3 patents)Syuzanna HarutyunyanSyuzanna Harutyunyan (2 patents)Gregory Fabien Sebastian BinotGregory Fabien Sebastian Binot (2 patents)Michel Joseph Maurice André GuillaumeMichel Joseph Maurice André Guillaume (5 patents)Stefan Marcel Herman LeursStefan Marcel Herman Leurs (3 patents)Dirk De SmaeleDirk De Smaele (2 patents)Ivan Joseph Maria VervestIvan Joseph Maria Vervest (1 patent)Dominique Paul Michel DeprÉDominique Paul Michel DeprÉ (0 patent)Gregory Fabien Sebastien BinotGregory Fabien Sebastien Binot (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Pharmaceuticals, Inc. (2 from 159 patents)

2. Janssen Pharmaceutica Nv (1 from 2,077 patents)


3 patents:

1. 9328108 - Process for preparing an intermediate of the macrocyclic protease inhibitor TMC 435

2. 8981082 - Process for preparing an intermediate of the macrocyclic protease inhibitor TMC 435

3. 8541578 - Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/10/2025
Loading…